Zota Health Care LImited - Asset Resilience Ratio

Latest as of March 2025: 0.68%

Zota Health Care LImited (ZOTA) has an Asset Resilience Ratio of 0.68% as of March 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check Zota Health Care LImited strategic capital allocation to assess the company's strategic physical and investment asset allocation.

Liquid Assets

Rs29.74 Million

≈ $321.63K USD Cash + Short-term Investments

Total Assets

Rs4.39 Billion

≈ $47.49 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2016–2025)

This chart shows how Zota Health Care LImited's Asset Resilience Ratio has changed over time. See how leveraged is Zota Health Care LImited's balance sheet to measure how much of total assets are equity-financed.

Liquid Assets Composition Over Time

This chart breaks down Zota Health Care LImited's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see market value of Zota Health Care LImited.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	Rs14.87 Million	0.34%
Short-term Investments	Rs14.87 Million	0.34%
Total Liquid Assets	Rs29.74 Million	0.68%

Asset Resilience Insights

Limited Liquidity: Zota Health Care LImited maintains only 0.68% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company maintains a balanced mix of cash and short-term investments.

Zota Health Care LImited Industry Peers by Asset Resilience Ratio

Compare Zota Health Care LImited's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Ascendis Pharma AS NASDAQ:ASND	Biotechnology	0.00%
Biomarin Pharmaceutical Inc NASDAQ:BMRN	Biotechnology	0.00%
Spyre Therapeutics Inc. NASDAQ:SYRE	Biotechnology	84.34%
3SBio Inc F:83B	Biotechnology	10.64%
Soleno Therapeutics Inc NASDAQ:SLNO	Biotechnology	20.15%
Jiangxi Fushine Pharmaceutical Co Ltd SHE:300497	Biotechnology	0.02%
Novavax Inc NASDAQ:NVAX	Biotechnology	53.87%
BB Biotech AG SW:BION	Biotechnology	0.05%

Annual Asset Resilience Ratio for Zota Health Care LImited (2016–2025)

The table below shows the annual Asset Resilience Ratio data for Zota Health Care LImited.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-03-31	0.68%	Rs29.74 Million ≈ $321.63K	Rs4.39 Billion ≈ $47.49 Million	+0.39pp
2024-03-31	0.29%	Rs6.56 Million ≈ $70.94K	Rs2.28 Billion ≈ $24.69 Million	-1.01pp
2023-03-31	1.29%	Rs20.46 Million ≈ $221.29K	Rs1.58 Billion ≈ $17.10 Million	-1.96pp
2022-03-31	3.25%	Rs45.22 Million ≈ $489.02K	Rs1.39 Billion ≈ $15.04 Million	+0.16pp
2021-03-31	3.09%	Rs26.39 Million ≈ $285.35K	Rs854.69 Million ≈ $9.24 Million	+1.26pp
2020-03-31	1.83%	Rs16.21 Million ≈ $175.29K	Rs884.79 Million ≈ $9.57 Million	+1.83pp
2019-03-31	0.00%	Rs120.00 ≈ $1.30	Rs896.07 Million ≈ $9.69 Million	+0.22pp
2018-03-31	-0.22%	Rs-2.00 Million ≈ $-21.63K	Rs917.94 Million ≈ $9.93 Million	+0.03pp
2016-03-31	-0.24%	Rs-1.08 Million ≈ $-11.63K	Rs440.52 Million ≈ $4.76 Million	--

pp = percentage points

About Zota Health Care LImited

NSE:ZOTA India Biotechnology

Market Cap

$418.05 Million

Rs38.66 Billion INR

Market Cap Rank

#13315 Global

#654 in India

Share Price

Rs1274.40

Change (1 day)

+4.36%

52-Week Range

Rs931.75 - Rs1687.00

All Time High

Rs1687.00